Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.
Hosted on MSN
China's rise threatens the drug world's status quo
China's emergence as a second hub of pharmaceutical innovation could trigger massive changes to the global drug market, including how treatments are regulated and priced in the U.S. Why it matters: ...
FILE PHOTO: Sara Carter speaks at the Conservative Political Action Conference (CPAC) annual meeting in National Harbor, Maryland, U.S., February 22, 2024. REUTERS/Amanda Andrade-Rhoades/File Photo ...
THE FIGHT against fentanyl, a synthetic opioid, is at the heart of America and China’s uneasy trade-war truce. The drug has killed more than 300,000 Americans since 2020 and related overdoses are the ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. America relies on China for many of its most essential hospital and outpatient medicines, ...
Chinese and U.S. anti-narcotics authorities arrested five suspects and seized a batch of drugs in a joint investigation of a drug smuggling and trafficking case, China's state-run news agency Xinhua ...
Former chemistry teacher Zhong Huijan’s Hansoh Pharmaceutical Group strikes potentially lucrative licensing deals with big pharma players, giving her a wealth boost. China’s growing pipeline of ...
Although President Trump's much-heralded "Most Favored Nation" drug policy promises to bring cheaper medication prices to Americans, it could come at the cost of the US losing its lead in biopharma ...
Danish drugmaker Novo Nordisk said Tuesday that its injectable weight-loss drug Wegovy has been approved in China, where the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results